Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

13. November 2025 08:00 ET | Quelle: Gate Bioscience

Gate Bioscience Announces $65 Million Oversubscribed Series B Financing to Advance Oral Molecular Gate Medicines into the Clinic

Gate Bioscience closes $65M Series B to advance molecular gates, oral drugs that eliminate disease proteins, into clinical trials for CNS/inflammation
06. Juni 2023 08:00 ET | Quelle: AAVantgarde Bio

AAVantgarde Closes €61 Million Series A Financing to Advance Two Therapeutic Programs into the Clinic

- Financing led by Atlas Venture and Forbion - Company created, incubated and seed financed by Sofinnova Partners MILAN, Italy, June 06, 2023 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), a...
09. Juni 2022 02:00 ET | Quelle: Forbion

Forbion announces first close of Forbion Growth Opportunities Fund II at €470 million

Forbion announces first close of Forbion Growth Opportunities Fund II at €470 million New fund to invest in late-stage European life sciences companiesInvestors include Pantheon, pension funds PME...
20. Dezember 2021 07:00 ET | Quelle: ARMGO

ARMGO Pharma raises $35 million to progress clinical studies of lead molecule ARM210 in cardiac and skeletal muscle diseases

ARMGO Pharma raises $35 million to progress clinical studies of lead molecule ARM210 in cardiac and skeletal muscle diseases Series B investment led by Forbion and joined by Pontifax and Kurma...